Postneoadjuvant Therapy Stage IV Gastric Cancer AJCC v8

9 clinical trials · Condition

Record	Firm	Date
Pembrolizumab and Lenvatinib for the Treatment of Advanced, Unresectable, or Metastatic Gastroesophageal Adenocarcinoma (NCT05041153)	M.D. Anderson Cancer Center	2022-02-14
Ramucirumab and Trifluridine/Tipiracil or Paclitaxel for the Treatment of Patients With Previously Treated Advanced Gastric or Gastroesophageal Junction Cancer (NCT04660760)	Academic and Community Cancer Research United	2021-06-16
Enhanced Outpatient Symptom Management to Reduce Acute Care Visits Due to Chemotherapy-Related Adverse Events (NCT05038254)	M.D. Anderson Cancer Center	2021-05-12
Radiation Therapy for the Treatment of Metastatic Gastrointestinal Cancers (NCT04221893)	University of California, San Francisco	2020-08-07
Paclitaxel for the Treatment of Gastric or Gastroesophageal Cancer (NCT04220827)	M.D. Anderson Cancer Center	2019-12-06
IRX-2, Cyclophosphamide, and Pembrolizumab in Treating Participants With Recurrent or Metastatic Gastric or Gastroesophageal Junction Cancer (NCT03918499)	City of Hope Medical Center	2019-04-19
Intravital Microscopy in Human Solid Tumors (NCT03823144)	Mayo Clinic	2019-02-28
Pembrolizumab in Treating Patients With Metastatic or Unresectable Gastroesophageal Adenocarcinoma (NCT03395847)	M.D. Anderson Cancer Center	2018-02-09

Every clearance here is in the API, with alerts when new ones post.